Bristol-Myers Squibb (BMY) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for Bristol-Myers Squibb (BMY) over the last 10 years.
|Medical||Large Cap Pharmaceutical||$88.674B||$20.776B|
|Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.|